1. Home
  2. NVAX vs USLM Comparison

NVAX vs USLM Comparison

Compare NVAX & USLM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • USLM
  • Stock Information
  • Founded
  • NVAX 1987
  • USLM 1948
  • Country
  • NVAX United States
  • USLM United States
  • Employees
  • NVAX N/A
  • USLM N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • USLM Other Metals and Minerals
  • Sector
  • NVAX Health Care
  • USLM Industrials
  • Exchange
  • NVAX Nasdaq
  • USLM Nasdaq
  • Market Cap
  • NVAX 2.0B
  • USLM 3.0B
  • IPO Year
  • NVAX 1995
  • USLM N/A
  • Fundamental
  • Price
  • NVAX $9.76
  • USLM $107.35
  • Analyst Decision
  • NVAX Buy
  • USLM
  • Analyst Count
  • NVAX 6
  • USLM 0
  • Target Price
  • NVAX $17.83
  • USLM N/A
  • AVG Volume (30 Days)
  • NVAX 7.2M
  • USLM 51.4K
  • Earning Date
  • NVAX 11-07-2024
  • USLM 11-08-2024
  • Dividend Yield
  • NVAX N/A
  • USLM 0.19%
  • EPS Growth
  • NVAX N/A
  • USLM 35.43
  • EPS
  • NVAX N/A
  • USLM 3.01
  • Revenue
  • NVAX $987,667,000.00
  • USLM $288,802,000.00
  • Revenue This Year
  • NVAX N/A
  • USLM N/A
  • Revenue Next Year
  • NVAX N/A
  • USLM N/A
  • P/E Ratio
  • NVAX N/A
  • USLM $35.32
  • Revenue Growth
  • NVAX N/A
  • USLM 8.77
  • 52 Week Low
  • NVAX $3.53
  • USLM $37.11
  • 52 Week High
  • NVAX $23.86
  • USLM $107.39
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 36.20
  • USLM 76.73
  • Support Level
  • NVAX $9.52
  • USLM $100.73
  • Resistance Level
  • NVAX $10.63
  • USLM $104.96
  • Average True Range (ATR)
  • NVAX 0.57
  • USLM 2.47
  • MACD
  • NVAX -0.12
  • USLM 0.02
  • Stochastic Oscillator
  • NVAX 9.97
  • USLM 92.96

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.

About USLM United States Lime & Minerals Inc.

United States Lime & Minerals Inc is engaged in the business of manufacturing lime and limestone products including PLS, quicklime, hydrated lime, and lime slurry. It supplies its products predominantly to the construction (including highway, road, and building contractors), industrial (including paper and glass manufacturers), environmental (including municipal sanitation and water treatment facilities and flue gas treatment processes), metals (including steel producers), oil and gas services, roof shingle manufacturers and agriculture (including poultry and cattle feed producers) industries. The company operates through its Lime and Limestone Operations segment.

Share on Social Networks: